|
|
skeletal system development
|
GO:0001501 |
356 |
0.293
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.278
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.264
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.246
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.226
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.225
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.183
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.177
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.169
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.166
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.159
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.158
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.158
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.139
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.134
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.131
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.130
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.124
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.119
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.118
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.115
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.115
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.112
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.112
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.108
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.106
|
|
|
|
protein autoprocessing
|
GO:0016540 |
2 |
0.101
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.100
|
|
|
|
regulation of sphingolipid mediated signaling pathway
|
GO:1902068 |
2 |
0.097
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.096
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.096
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.095
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.094
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.094
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.092
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.089
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.088
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.085
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.085
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.081
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.081
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.079
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.078
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.076
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.075
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.075
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.074
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.074
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.071
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.071
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.070
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.070
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.070
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.069
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.068
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.068
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.067
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.067
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.067
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.066
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.065
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.065
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.065
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.065
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.065
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.064
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.063
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.063
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.062
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.061
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.061
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.060
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.060
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.060
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.060
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.059
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.059
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.058
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.058
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.058
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.058
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.058
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.057
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.056
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.055
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.055
|
|
|
|
binding of sperm to zona pellucida
|
GO:0007339 |
34 |
0.054
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.054
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.053
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.053
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.053
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.052
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.052
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.052
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.051
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.051
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.051
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.050
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.050
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.050
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.050
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.050
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.049
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.049
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.049
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.049
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.049
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.048
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.048
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.048
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.048
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.047
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.047
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.047
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.047
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.047
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.045
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.045
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.045
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.045
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.045
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.045
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.045
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.044
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.044
|
Human |
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.044
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.043
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.043
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.042
|
|
|
|
regulation of macrophage activation
|
GO:0043030 |
17 |
0.042
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.042
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.041
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.041
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.041
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.041
|
Human |
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.041
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.040
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.040
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.040
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.040
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.040
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.040
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.040
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.040
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.040
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.040
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.039
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.039
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.039
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.038
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.038
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.038
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.038
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.038
|
Mouse |
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.037
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.037
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.037
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.037
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.037
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.037
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.037
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.037
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.037
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.036
|
|
|
|
mammary placode formation
|
GO:0060596 |
4 |
0.036
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.036
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.036
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.036
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.036
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.036
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.036
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.035
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.035
|
|
|
|
embryonic digestive tract development
|
GO:0048566 |
27 |
0.035
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.035
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.035
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.035
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.035
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.035
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.035
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.035
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.035
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.035
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.035
|
|
|
|
cell differentiation in hindbrain
|
GO:0021533 |
24 |
0.034
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.034
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.034
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.034
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.034
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.034
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.033
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.033
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.033
|
Mouse |
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.033
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.033
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.033
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.032
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.032
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.032
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.032
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.032
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.032
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.032
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.032
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.032
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.032
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.032
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.032
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.032
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.032
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.031
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.031
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.031
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.031
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.031
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.031
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.031
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.031
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.031
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.031
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.031
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.031
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.031
|
|
|
|
positive regulation of organ growth
|
GO:0046622 |
29 |
0.030
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.030
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.030
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.030
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.030
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.030
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.030
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.030
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.030
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.030
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.030
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.030
|
Human |
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.030
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.030
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.030
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.030
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.030
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.030
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.029
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.029
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.029
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.029
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.029
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.029
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.029
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.029
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.029
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.029
|
Mouse |
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.029
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.029
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.028
|
|
|
|
motor neuron migration
|
GO:0097475 |
4 |
0.028
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.028
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.028
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.028
|
|
|
|
sperm egg recognition
|
GO:0035036 |
37 |
0.028
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.027
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.027
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.027
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.027
|
|
|
|
positive regulation of immature t cell proliferation
|
GO:0033091 |
4 |
0.027
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.027
|
|
|
|
peptide hormone processing
|
GO:0016486 |
9 |
0.027
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.027
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.027
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.027
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.027
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.027
|
|
|
|
regulation of fat cell proliferation
|
GO:0070344 |
4 |
0.027
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.027
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.027
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.027
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.026
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.026
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.026
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.026
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.026
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.026
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.026
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.026
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.026
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.026
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.026
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.026
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.026
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.026
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.025
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.025
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.025
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.025
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.025
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.025
|
|
|
|
l glutamate import into cell
|
GO:1990123 |
3 |
0.025
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.025
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.025
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.025
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.025
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.025
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.025
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.025
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.025
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.025
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.025
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
13 |
0.024
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.024
|
Human |
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.024
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.024
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.024
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.024
|
|
|
|
platelet aggregation
|
GO:0070527 |
20 |
0.024
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.024
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.024
|
|
|
|
regulation of non canonical wnt signaling pathway
|
GO:2000050 |
12 |
0.024
|
|
|
|
lobar bronchus development
|
GO:0060482 |
6 |
0.024
|
|
|
|
mitotic chromosome condensation
|
GO:0007076 |
1 |
0.024
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.024
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
23 |
0.024
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.024
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.023
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.023
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.023
|
|
|
|
endothelial cell morphogenesis
|
GO:0001886 |
9 |
0.023
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.023
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.023
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.023
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.023
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.023
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.023
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.023
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.023
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.023
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.023
|
Human |
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.023
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.023
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.023
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.023
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.023
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.023
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.023
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.023
|
|
|
|
mesenchymal cell proliferation involved in ureter development
|
GO:0072198 |
4 |
0.023
|
|
|
|
axis elongation
|
GO:0003401 |
30 |
0.022
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.022
|
|
|
|
cerebellar cortex morphogenesis
|
GO:0021696 |
32 |
0.022
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.022
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.022
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.022
|
|
|
|
enkephalin processing
|
GO:0034230 |
1 |
0.022
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.022
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.022
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.022
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.022
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.022
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.022
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.022
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.022
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.022
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.022
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.021
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.021
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.021
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.021
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.021
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.021
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.021
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.021
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.021
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.021
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.021
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.021
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.021
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.021
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.021
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.021
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.021
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.021
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.021
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.021
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.021
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.021
|
|
|
|
amino acid import into cell
|
GO:1902837 |
4 |
0.021
|
|
|
|
negative regulation of cardiac chamber morphogenesis
|
GO:1901220 |
2 |
0.021
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.021
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.021
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.021
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.021
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.021
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.020
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.020
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.020
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.020
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.020
|
|
|
|
cellular response to arsenic containing substance
|
GO:0071243 |
4 |
0.020
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.020
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.020
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.020
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.020
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.020
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.020
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.020
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.020
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.020
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.020
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.020
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.020
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.020
|
|
|
|
t cell apoptotic process
|
GO:0070231 |
39 |
0.020
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.020
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.020
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.020
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.020
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.020
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901228 |
4 |
0.020
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.020
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.020
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.020
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.020
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.020
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.019
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.019
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.019
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.019
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.019
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.019
|
|
|
|
organ induction
|
GO:0001759 |
21 |
0.019
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.019
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.019
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.019
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.019
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.019
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.019
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.019
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.019
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.019
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.019
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.019
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.019
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.018
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.018
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.018
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.018
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.018
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.018
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.018
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.018
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.018
|
|
|
|
anterior commissure morphogenesis
|
GO:0021960 |
6 |
0.018
|
|
|
|
male genitalia morphogenesis
|
GO:0048808 |
4 |
0.018
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.018
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.018
|
|
|
|
uterus development
|
GO:0060065 |
16 |
0.018
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.018
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.018
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.018
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.018
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.018
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.018
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.018
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.018
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.018
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.018
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.018
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.018
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.018
|
|
|
|
positive regulation of chondrocyte differentiation
|
GO:0032332 |
13 |
0.018
|
Human |
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.018
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.017
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.017
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.017
|
|
|
|
forebrain radial glial cell differentiation
|
GO:0021861 |
4 |
0.017
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.017
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.017
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.017
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.017
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.017
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.017
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.017
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.017
|
|